Trial Profile
Phase II study of Glivec (imatinib mesylate) in patients with advanced neuroblastoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2011
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Neuroblastoma
- Focus Biomarker; Therapeutic Use
- 25 May 2011 New trial record